- Reaction score
- 6,428
Gyno doesn't shrink or go away with medication. Several specialists told me the same.
Then your "specialists" were ill informed. Or perhaps they were reluctant to use hormone-altering medication for something benign and cosmetic like gynecomastia.
The bodybuilding forums are full of people running SERMS/AIs to block possible gyno or reduce existing gyno. Again, this doesn't really work for gyno that has become fibrotic - surgery is the only option then. But it can work for gyno in its earlier stages.
http://www.ncbi.nlm.nih.gov/pubmed/3526085
"Seven of ten patients experienced a decrease in the size of their gynecomastia due to tamoxifen (P less than 0.005). Overall, the decrease for gynecomastia for the whole group was significant (P less than 0.01). There was no beneficial effect of placebo (P greater than 0.1).
Therefore, antiestrogenic treatment with tamoxifen may represent a safe and effective mode of treatment for selected cases of cosmetically disturbing or painful gynecomastia."
http://www.ncbi.nlm.nih.gov/pubmed/9426725
Five patients experienced complete resolution of breast and nipple pain on tamoxifen 10 mg/day within the first month. The other patient had to be treated with 30 mg/day for 1 additional month, which subsequently resulted in pain resolution.
These preliminary results suggest that low-dose tamoxifen is useful in treating painful gynecomastia for those patients on flutamide/finasteride combination therapy for advanced prostate carcinoma.
http://www.ncbi.nlm.nih.gov/pubmed/16217274
Tamoxifen may also mitigate or resolve gynecomastia during its early or proliferative phase. In severe long-standing gynecomastia surgery is warranted since medical therapies are less likely to succeed.
http://www.ncbi.nlm.nih.gov/pubmed/15238910
Mean reduction in breast nodule diameter was 2.1 cm (95% CI 1.7, 2.7, P <.0001) after treatment with tamoxifen and 2.5 cm (95% CI 1.7, 3.3, P <.0001) with raloxifene. Some improvement was seen in 86% of patients receiving tamoxifen and in 91% receiving raloxifene, but a greater proportion had a significant decrease (>50%) with raloxifene (86%) than tamoxifen (41%). No side effects were seen in any patients.